Divya Sharma | Pharmacology | Research Excellence Award

Published on by Young Scientists Awards

Research Excellence Award

Divya Sharma
Vellore Institute of Technology, India
Divya Sharma
Affiliation Vellore Institute of Technology
Country India
Scopus ID 59553841100
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology
Event International Young Scientists Award
ORCID 0009-0004-3376-0847

Divya Sharma is a researcher associated with Vellore Institute of Technology, India, with academic interests in pharmacology and related biomedical sciences. Her research profile reflects engagement in scientific studies addressing pharmaceutical sciences, therapeutic investigations, and interdisciplinary health-related research. Through scholarly publications and indexed research contributions, Sharma has participated in the advancement of scientific understanding within pharmacological and healthcare-oriented domains.[1]

Abstract

This article summarizes the academic profile and scholarly activities of Divya Sharma in the field of pharmacology. Her research contributions include publication-based investigations and interdisciplinary studies associated with pharmaceutical sciences and biomedical research. The profile highlights publication metrics, citation indicators, and academic participation relevant to contemporary scientific research practices.[2]

Keywords

  • Pharmacology
  • Biomedical Research
  • Pharmaceutical Sciences
  • Healthcare Research
  • Scientific Publications

Introduction

Pharmacology research contributes significantly to healthcare innovation and therapeutic development through scientific experimentation and evidence-based investigations. Researchers in this field support advancements in drug discovery, treatment evaluation, and biomedical understanding. Divya Sharma’s scholarly profile reflects participation in research activities connected with pharmaceutical sciences and scientific communication through academic publishing platforms.[3]

Research Profile

Divya Sharma is affiliated with Vellore Institute of Technology, India. Her documented academic metrics include four research documents, eight citations, and an h-index of two. Her academic work is primarily associated with pharmacology and interdisciplinary biomedical studies involving healthcare-related scientific investigations.[1]

Research Contributions

  • Participation in pharmacological and biomedical research studies.
  • Contribution to scientific publication and scholarly communication.
  • Research involvement in healthcare-oriented scientific investigations.
  • Engagement in interdisciplinary pharmaceutical science research initiatives.

Publications

The publication profile of Divya Sharma includes indexed scholarly articles associated with pharmacology and healthcare sciences. Her research output demonstrates participation in academic dissemination through recognized scholarly platforms and scientific databases. Citation indicators further reflect the visibility and accessibility of her published work within academic communities.[2]

Research Impact

The research impact associated with Sharma’s academic work is reflected through citation activity, publication records, and scholarly indexing metrics. Her work contributes to broader scientific discussions concerning pharmacological investigations and biomedical applications. The documented citation profile and research participation indicate continuing academic engagement in scientific research activities.

Award Suitability

Based on the available academic profile and research documentation, Divya Sharma demonstrates qualifications relevant to recognition under the International Young Scientists Award program. Her scholarly activities, research publications, and participation in pharmacology-focused scientific studies align with the objectives commonly associated with research excellence and young scientist recognition initiatives.[6]

Conclusion

Divya Sharma academic profile illustrates active participation in pharmacology and biomedical research through publications, citation-based contributions, and scholarly engagement. Her work reflects continuing involvement in scientific communication and healthcare-related investigations. The profile presented in this article provides a concise overview of her academic achievements and research-oriented contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Divya Sharma, Author ID 59553841100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59553841100
  2. Google Scholar. (n.d.). Publication and citation profile of Divya Sharma.
    https://scholar.google.com/citations?hl=en&user=VsCMB4QAAAAJ&view_op=list_works&authuser=1&gmla=AIqSsVuOD0ny7xiZ4GIdOG3Ysew9JTNbTucp0boEKBLSh7lhzv6rBFfsUcdfByyt0h1ZOtsgMYoS-wb1Sn3EVEao
  3. Orcid. (n.d.). Orcid author details: Divya Sharma, Author ID 0009-0004-3376-0847.
    https://orcid.org/0009-0004-3376-0847
  4. International Young Scientists Award. (n.d.). Award program and academic recognition criteria.
    https://youngscientistawards.com/

Akash Vikal | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73

Lakshmanan Govindan | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Lakshmanan Govindan | Pharmacology | Young Scientist Award

Sri Lakshmi Narayana Institute of Medical Sciences | India

Dr Lakshmanan Govindan is a dedicated researcher in Botany with expertise in medicinal plant studies and bioactive compound analysis. His research focuses on isolating and characterizing natural compounds with anticancer, antidiabetic, and antimicrobial potential. He has contributed extensively to scientific literature, including research articles, patents, and book chapters in the fields of biotechnology and phytochemistry. His work also explores green synthesis of nanoparticles and their biomedical applications. He actively engages in academic evaluation, research reviewing, and interdisciplinary scientific advancements. His scholarly impact is reflected in 575 citations across 574 documents, with 28 published works and an h-index of 7, demonstrating consistent contributions and recognition in his field.

Citation Metrics (Scopus)

600500

400

300

200

100

0

Citations
575

Documents
28

h-index
7

 


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

 

Ravi Prakash Degala | Pharmacology | Young Researcher Award

Published on by Young Scientists Awards

Dr. Ravi Prakash Degala | Pharmacology | Young Researcher Award

Pydah College of Pharmacy | India

Dr. Ravi Prakash Degala is a pharmaceutical researcher specializing in clinical research, pharmacotherapy, and pharmacovigilance with a focus on improving patient outcomes and drug safety. His research spans diverse areas including disease management, adverse drug reactions, oncology, cardiology, and evidence-based pharmacy practice. He has contributed over 35 research publications, along with patents, book chapters, and edited academic books, reflecting strong scholarly productivity. His research profile includes 145 citations, an h-index of 3, and an i10-index of 1, indicating steady academic impact. He is actively engaged in advancing pharmaceutical sciences through research, innovation, and academic contributions.


View Google Scholar Profile

Featured Publications

Shivang Shukla | Pharmacy | Young Researcher Award

Published on by Young Scientists Awards

Mr. Shivang Shukla l Pharmacy
| Young Researcher Award

Jagannath University | India

The research focuses on advancing pharmacological science through multidisciplinary approaches involving drug discovery, nanotechnology, computational modeling, and translational pharmacology. Current investigations explore the computational identification of skeletal muscle-specific AMPK activators for type-2 diabetes therapy, aiming to enhance metabolic regulation and therapeutic efficacy. Additional studies examine the cardioprotective potential of Artocarpus heterophyllus against isoprenaline-induced myocardial infarction and the neuroprotective role of Coenzyme Q10 as an adjuvant to nanostructured lipid carriers loaded with Adenium obesum in ethanol-induced cognitive impairment models. The work integrates molecular biology, biochemistry, and pharmacokinetic analysis to identify novel therapeutic pathways and biomarker targets. Emphasis is also placed on nanocarrier-based drug delivery for neurological and cardiovascular disorders, focusing on improving bioavailability and site-specific targeting. Parallel research on nanotherapeutics addresses challenges in treating conditions such as Alzheimer’s disease, psoriasis, and Clostridioides difficile infection. The studies utilize a combination of in silico, in vitro, and in vivo methodologies to develop innovative solutions in pharmacology and toxicology. Through experimental validation and advanced modeling, this research contributes to understanding drug mechanisms, enhancing safety profiles, and formulating next-generation therapeutics for complex diseases, thereby supporting the global goal of precision medicine and sustainable healthcare innovation.

Featured Publications

Rai, A., Shukla, S., Gupta, R. K., & Mishra, A. (2025). ALS: A silent slayer of motor neurons. Traditional Chinese herbal medicine as an effective therapy. Current Pharmaceutical Design.

Singh, V., Ravindranath, S. K., Verma, H., Shukla, S., Rai, A., Patani, T., Mishra, T., Mishra, A., & Gupta, R. K. (2025). Harnessing traditional Chinese medicine for wound healing and modern wound models: An overview. Pharmacological Research: Modern Chinese Medicine.

Pal, R., Shukla, S., Rai, A., & Sharma, A. (2025, September 25). Nano-brain revolution in Alzheimer’s disease: A new era of brain drug delivery. [Book].

Pal, R., Shukla, S., Gupta, R. K., Rai, A., & Sharma, P. (2025, September 13). From ancient roots to nano routes: Targeted delivery of Ginkgo and Gastrodia for Parkinson’s disease (PD) treatment. [Book].

Blaise Dondji | Drug discovery | Best Researcher Award

Published on by Young Scientists Awards

Prof. Blaise Dondji | Drug discovery | Best Researcher Award

Distinguished Professor , Central Washington University , United States

Dr. Blaise Dondji is a Distinguished Professor in the Department of Biological Sciences at Central Washington University (CWU), USA. He specializes in immunology, infectious diseases, and parasitology, with extensive experience in teaching, mentoring, and research. Holding a Ph.D. in Parasitology from the University of Jos, Nigeria, and postdoctoral training at Yale School of Medicine and Hebrew University, Dr. Dondji has made significant contributions to parasitic disease research and immunology. His work focuses on vector-borne diseases, vaccine development, and host-pathogen interactions. He has received prestigious grants from NIH, Volkswagen Foundation, and Keck Foundation. Recognized for his teaching excellence, he has been awarded multiple faculty mentorship and excellence awards at CWU. Dr. Dondji is also actively involved in academic service, grant writing, and diversity initiatives. His dedication to research and student success continues to shape the next generation of scientists.

Profile

Scopus

🎓 Education 

Dr. Blaise Dondji holds a diverse and extensive academic background in biological sciences, specializing in parasitology and immunology. He earned his Ph.D. in Parasitology from the University of Jos, Nigeria, in 1999, following an M.Sc. in Entomology & Parasitology from the same institution in 1993. Before that, he completed both an M.Phil. (1991) and an M.Sc. (1990) in Animal Biology & Physiology at the University of Yaoundé, Cameroon, where he also obtained his B.Sc. in Zoology in 1989. His postdoctoral training includes Molecular Parasitology at the Hebrew University in Jerusalem, Israel (2002) and Immunology & Infectious Diseases at the Yale School of Medicine, USA (2007). His academic journey has been enriched by multiple prestigious fellowships, including those from UNESCO and the Brazilian Council for Scientific and Technological Advancement, equipping him with a strong foundation in parasitology, immunology, and global health research.

🏢 Experience 

Dr. Dondji is a Distinguished Professor at Central Washington University, where he has been a faculty member since 2008. He has served as Professor, Associate Professor, and Assistant Professor in the Department of Biological Sciences, mentoring undergraduate and graduate students. Additionally, he has held roles as Director of the Keck-Murdock Flow Cytometry Facility and a pre-medical and pre-dental advisor. Prior to CWU, he was a faculty member at Yale School of Medicine, supervising research in infectious diseases. His earlier career includes serving as a Senior Lecturer at the University of Ngaoundéré, Cameroon, and as a Visiting Lecturer at institutions such as Quinnipiac University and the Université Paris-Sorbonne. With decades of teaching experience in immunology, molecular biology, and parasitology, Dr. Dondji has contributed significantly to the academic and research community, shaping the next generation of scientists through his expertise and mentorship.

🏆 Awards & Honors 

Dr. Dondji has been widely recognized for his excellence in teaching, mentoring, and research. He received the 2022 Distinguished Faculty – Teaching Award at CWU, adding to previous accolades such as the 2019 Career Influencer Award and the 2018 Faculty Mentor of the Year Award. His contributions to student success have earned him multiple recognitions, including the 2013 Most Inspirational Faculty Award and the 2016 Professors’ Excellence Award from the National Residence Hall Honorary. His impact on the scientific community is also reflected in prestigious research fellowships from the Volkswagen Foundation, UNESCO, and the Brazilian Council for Scientific and Technological Advancement. He has also received major research grants, including an NIH R15 grant and funding from the Keck Foundation and Murdock Charitable Trust, highlighting his leadership in research and education.

🔬 Research Focus 

Dr. Dondji’s research focuses on immunology, parasitology, and infectious diseases, with an emphasis on host-pathogen interactions and vaccine development. His studies explore novel immunological approaches to combat parasitic infections, particularly those caused by helminths and protozoa. He has contributed significantly to understanding immune responses to parasitic diseases, investigating mechanisms of host resistance and susceptibility. His research also extends to vector-borne diseases, particularly mosquito biology and control strategies to curb malaria and other mosquito-transmitted infections. Through his work, he has secured major funding, including NIH grants, and has established state-of-the-art immunological research methodologies. Additionally, he has been actively involved in promoting public health awareness and vaccine research, furthering global efforts to mitigate the burden of infectious diseases in sub-Saharan Africa and beyond.

🔹 Conclusion

Given his exceptional research output, global impact, and dedication to scientific advancements, Dr. Blaise Dondji is a highly suitable candidate for the Best Researcher Award. His pioneering research, influential mentorship, and ability to secure significant funding position him as a distinguished scientist whose contributions have greatly advanced the field of immunology and infectious disease research.

Publication

Publication: “Distribution and ecological aspects of sand fly species from Kousseri, an endemic focus of visceral leishmaniasis in Northern Cameroon”

Authors: Tebo-Nzesseu Thierry Rostand, Tateng Ngouateu Aime, Ngouateu Omer Bébé Kenfack, Vincent Khan Payne, Blaise Dondji

Journal: Frontiers in Tropical Diseases

Year: 2024

Citations: 0

Publication: “Ecological site distribution of sand fly species of Mokolo, an endemic focus of cutaneous leishmaniasis in northern Cameroon”

Authors: Aime Tateng Ngouateu, Omer Bébé Ngouateu Kenfack, Vincent Khan Payne, Andreas Krüger, Blaise Dondji

Journal: Acta Tropica

Year: 2023

Citations: 3

Publication: “Assessment of the anthelmintic activity and toxicity of metabolites of Dalea pogonathera (Fabaceae)”

Authors: Victoria McPherson, Haley Wolhart, Lindsay Engels, Gil N. Belofsky, Blaise Dondji

Journal: Phytochemistry Letters

Year: 2022

Citations: 1

 

 

 

 

Virginia M. Concato-Lopes | drug-discovery | Best Researcher Award

Published on by Young Scientists Awards

Dr. Virginia M. Concato-Lopes | toxicology Award |Best Researcher Award

👨‍🏫Profile Summary

With a Ph.D. and Master’s in Experimental Pathology from Universidade Estadual de Londrina, Brazil, and ongoing postdoctoral research at Cedars-Sinai Medical Center, I specialize in the biogenesis of large oncosomes. My academic journey includes a Bachelor’s in Biomedicine from Universidade do Norte do Paraná. I’ve provided academic advisory for research projects investigating the antiproliferative properties of oregano essential oil in cancer cells. Passionate about advancing biomedical knowledge, I contribute to cutting-edge research and mentorship initiatives. For further information, please refer to my published papers or contact the respective academic institutions directly.

🌐 Professional Profiles

🎓 Education

Postdoctoral Fellow in Biogenesis of Large Oncosomes Cedars-Sinai Medical Center, Los Angeles, California, United States (2023 – Current), Ph.D. in Experimental Pathology Universidade Estadual de Londrina, Londrina, Paraná, Brazil (2019 – 2023), Master in Experimental Pathology
Universidade Estadual de Londrina, Londrina, Paraná, Brazil (2017 – 2019) Bachelor of Biomedicine Universidade do Norte do Paraná, Paraná, Brazil (2013 – 2016).

👨‍🏫Academic Advisory

Milena Cremer de Souza: Evaluating the antiproliferative capacity of Oregano Essential Oil (Origanum vulgare) on PC-3 prostate cancer cells. (2022) Degree: Ciências Biológicas (Biological Sciences) Institution: Universidade Estadual do Norte do Paraná Funding: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Maria Beatriz Madureira: Exploring the antiproliferative activity of oregano oil in liver carcinoma tumor lines. (2021) Degree: Biomedicine Institution: Philadelphia University Center  For further details, please refer to the respective academic papers or contact the institutions directly.

Published article (first author publication)

  1. Concato-Lopes, V. M., Gonçalves-Lens, M. D., Tomiotto-Pellissier, F., Detoni, M. B., Cruz, E. M. S., Bortoleti, B. T. D. S., Carloto, A. C. M., Rodrigues, A. C. J., Silva, T. F., Siqueira, E. D. S., De Matos, R. L. N., Alves Cardoso, I. L., Conchon-Costa, I., Lazarin-Bidoia, D., Arakawa, N. S., Dekker, R. F., Mantovani, M. S., & Pavanelli, W. R. Trilobolide-6-O-isobutyrate from Sphagneticola trilobata acts by inducing oxidative stress, metabolic changes and apoptosis-like processes by caspase 3/7 activation of human lung cancer cell lines. Phytomedicine, v. 155536, 2024.
  1. Concato-Lopes, V. M., Silva, T. F., Detoni, M. B., Cruz, E. M. S., Gonçalves, M. D., Da Silva Bortoleti, B. T., Tomiotto-Pellissier, F., Carloto, A. C. M., Madureira, M. B., Rodrigues, A. C. J., Schirmann, J. G., Barbosa-Dekker, A. M., Dekker, R. F., Conchon-Costa, I., Panis, C., Lazarin-Bidóia, D., Miranda-Sapla, M. M., Mantovani, M. S., & Pavanelli, W. R. 3,3′,5,5′-Tetramethoxybiphenyl-4,4’diol triggers oxidative stress, metabolic changes, and apoptosis-like process by reducing the PI3K/AKT/NF-κB pathway in the NCI-H460 lung cancer cell line. Biomedicine & Pharmacotherapy, 170, 115979, 2024.
  1. Concato, Virginia Marcia; Tomiotto-Pellissier, Fernanda; Silva, Taylon Felipe; Gonçalves, Manoela Daiele; Da Silva Bortoleti, Bruna Taciane; Detoni, Mariana Barbosa; Da Silva Siqueira, Elaine; Jacob Rodrigues, Ana Carolina; Schirmann, Jéseka Gabriela; De Melo Barbosa-Dekker, Aneli; Costa, Idessania Nazareth; Conchon-Costa, Ivete; Miranda-Sapla, Milena Menegazzo; Mantovani, Mario Sergio; Pavanelli, Wander Rogério. 3,3-,5,5–tetramethoxybiphenyl-4,4-diol induces cell cycle arrest in G2/M phase and apoptosis in human non-small cell lung cancer A549-cells. Chemico-Biological Interactions, v. 2020, p. 109133, 2020.

 

Published book chapters

  1. Silva, T. F.; Tomiotto-Pellissier, F.; Sanfelice, Raquel Arruda; Gonçalves, Manoela Daiele; Bortoleti, Bruna; Detoni, Mariana Barbosa; Rodrigues, Ana Carolina Jacob; Carloto, Amanda; Concato, Virginia Marcia; Siqueira, Elaine Da Silva; Costa, I. N.; Pavanelli, Wander; Conchon-Costa, Ivete; Miranda-Sapla, M. M. A 21st Century Evil: Immunopathology and New Therapies of COVID-19 In: CORONAVIRUS DISEASE (COVID-19): PATHOPHYSIOLOGY, EPIDEMIOLOGY, CLINICAL MANAGEMENT AND PUBLIC HEALTH RESPONSE.1 ed.Lausanne: Frontiers Media SA, 2023, v.C, p. 164-194.

 

  1. Fagundes, Tatiane Renata; Kawassaki, A. C. B.; Concato, Virginia Marcia; Assolini, João Paulo; Silva, Taylon Felipe; Goncalves, M. D.; Da Silva Siqueira, Elaine; Sahd, C. S.; Inoue, Fabricio Seidy Ribeiro; Silva, T. P.; Lima, D. M.; Ferreira, Mariane Okamoto; Conchon-Costa, Ivete; Pavanelli, W. R.; Panis, Carolina. Impact of Pesticides on Immune-Endocrine Disorders and Its Relationship to Cancer Development In: Handbook of Cancer and Immunology.30, 2023, p. 1-30.

 

  1. Tomiotto-Pellissier, Fernanda; Gonçalves, Manoela Daiele; Silva, Taylon Felipe; Concato, Virgínia Márcia; Bortoleti, Bruna Taciane da Silva; Arakawa, Nilton Syogo; Conchon-Costa, Ivete; Pavanelli, Wander Rogério; and Panis, Carolina. Structure-Activity Relationship (SAR) Studies on Anti-Cancer Bioactive Natural Products. In: Atta-ur-Rahman. Studies in Natural Products Chemistry. Netherlands: Elsevier. Volume 72, 1st edition, 2022. ISBN: 978-0-128-23944-5.

Published book chapters

  1. Silva, T. F.; Tomiotto-Pellissier, F.; Sanfelice, Raquel Arruda; Gonçalves, Manoela Daiele; Bortoleti, Bruna; Detoni, Mariana Barbosa; Rodrigues, Ana Carolina Jacob; Carloto, Amanda; Concato, Virginia Marcia; Siqueira, Elaine Da Silva; Costa, I. N.; Pavanelli, Wander; Conchon-Costa, Ivete; Miranda-Sapla, M. M. A 21st Century Evil: Immunopathology and New Therapies of COVID-19 In: CORONAVIRUS DISEASE (COVID-19): PATHOPHYSIOLOGY, EPIDEMIOLOGY, CLINICAL MANAGEMENT AND PUBLIC HEALTH RESPONSE.1 ed.Lausanne: Frontiers Media SA, 2023, v.C, p. 164-194.

 

  1. Fagundes, Tatiane Renata; Kawassaki, A. C. B.; Concato, Virginia Marcia; Assolini, João Paulo; Silva, Taylon Felipe; Goncalves, M. D.; Da Silva Siqueira, Elaine; Sahd, C. S.; Inoue, Fabricio Seidy Ribeiro; Silva, T. P.; Lima, D. M.; Ferreira, Mariane Okamoto; Conchon-Costa, Ivete; Pavanelli, W. R.; Panis, Carolina. Impact of Pesticides on Immune-Endocrine Disorders and Its Relationship to Cancer Development In: Handbook of Cancer and Immunology.30, 2023, p. 1-30.

 

  1. Tomiotto-Pellissier, Fernanda; Gonçalves, Manoela Daiele; Silva, Taylon Felipe; Concato, Virgínia Márcia; Bortoleti, Bruna Taciane da Silva; Arakawa, Nilton Syogo; Conchon-Costa, Ivete; Pavanelli, Wander Rogério; and Panis, Carolina. Structure-Activity Relationship (SAR) Studies on Anti-Cancer Bioactive Natural Products. In: Atta-ur-Rahman. Studies in Natural Products Chemistry. Netherlands: Elsevier. Volume 72, 1st edition, 2022. ISBN: 978-0-128-23944-5.

 Published Abstracts

 

  1. Rodrigues, A. C. J.; Silva, T. F.; Detoni, Mariana Barbosa; Concato, Virginia Marcia; Tomiotto-Pelissier, Fernanda; Miranda-Sapla, M. M.; Bortoleti, Bruna; Gonçalves, M. D.; Carloto, Amanda; Sanfelice, Raquel Arruda; Cruz, Ellen Mayara Sousa ; Morais, J. M. B.; Bidóia, Danielle Larazin; Costa, I. N.; Pavanelli, W. R.; Conchon-Costa, I. A hiperglicemia modula a capacidade leishmanicida dos macrófagos, com redução de mediadores pró inflamatórios e aumento na atividade enzimática de sod e catalase In: XIII Simpósio Sul de Imunologia, 2022, Blumenal – SC. XIII Simpósio Sul de Imunologia. , 2022.

 

  1. Carloto, Amanda; Silva, T. F.; Detoni, Mariana Barbosa; Concato, Virginia Marcia; Tomiotto-Pelissier, Fernanda; Miranda-Sapla, M. M.; Bortoleti, Bruna; Gonçalves, Manoela Daiele; Rodrigues, Ana Carolina Jacob; Sanfelice, Raquel Arruda; Cruz, Ellen Mayara Sousa; Bidóia, Danielle Larazin; Costa, I. N.; Pavanelli, W. R.; Conchon-Costa, I. Diabetes reduz estresse oxidativo e favorece a infecção em camundongos c57bl/6 por leishmania amazonensis In: XIII Simpósio Sul de Imunologia, 2022, Blumenal – SC. XIII Simpósio Sul de Imunologia. , 2022.

 

  1. Caputo, W. L.; Silva, T. F.; Detoni, Mariana Barbosa; Concato, Virginia Marcia; Tomiotto-Pellissier, F.; Miranda-Sapla, M. M.; Bortoleti, Bruna; Gonçalves, M. D.; Jacob Rodrigues, Ana Carolina; Sanfelice, Raquel Arruda; Cruz, Ellen Mayara Sousa ; Carloto, Amanda; Bidóia, Danielle Larazin; Costa, I. N.; Pavanelli, W. R.; Conchon-Costa, I. Estímulo hiperglicêmico altera a resposta macrofágica desencadeada pela infecção por leishmania amazonensis In: XIII Simpósio Sul de Imunologia, 2022, Blumenal – SC. XIII Simpósio Sul de Imunologia. , 2022.

 

📚Top Noted Publication

 

3,3′,5,5′-Tetramethoxybiphenyl-4,4’diol triggers oxidative stress, metabolic changes, and apoptosis-like process by reducing the PI3K/AKT/NF-κB pathway in the NCI-H460 lung cancer cell line